Coagulation Market Worth $10.85 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
16. Oktober 2023 08:13 ET
|
The Insight Partners
Pune, India, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Coagulation or clotting is the process by which blood turns from a liquid into a gel and forms a blood clot. This potentially leads to hemostasis,...
Antiplatelet Drugs Market to Hit USD 4.1 Bn by 2031 Due to the Increase in Prevalence of Cardiovascular Diseases, Latest Study by TMR
20. März 2023 17:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, March 21, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research, the global antiplatelet drugs market size was valued USD 2.1 Bn in 2022 and it is...
AAPS Executive Director in Journal of American Physicians and Surgeons Discusses Whether Blood Clots After COVID Vaccines Are an Ignored Crisis
07. Dezember 2022 11:00 ET
|
Association of American Physicians and Surgeons (AAPS)
TUCSON, Ariz., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Despite official reassurances that adverse effects of COVID vaccines are rare or mild, some patients still have concerns, and social media is filled...
Low Molecular Weight Heparin Market Size Worth $5,733.96 Mn, Globally, by 2028 at 6.6% CAGR - Exclusive Report by The Insight Partners
11. Februar 2022 06:26 ET
|
The Insight Partners
New York, Feb. 11, 2022 (GLOBE NEWSWIRE) -- The latest research study on “Low Molecular Weight Heparin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Enoxaparin,...
Blood Clot Risk among People with Cancer
02. Oktober 2019 09:35 ET
|
Stop the Clot, Spread the Word™
GAITHERSBURG, Md., Oct. 02, 2019 (GLOBE NEWSWIRE) -- The National Blood Clot Alliance (NBCA) and the Centers for Disease Control and Prevention (CDC) are rolling out a new suite of resources from...
AHA Perspective on FDA Committee Decision on Rivaroxaban
08. September 2011 18:26 ET
|
American Heart Association
DALLAS, Sept. 8, 2011 (GLOBE NEWSWIRE) -- The American Heart Association notes the FDA advisory committee's recommendation today to give market approval for rivaroxaban, an oral anticoagulant drug,...